Stock Events

Stock Events

Crinetics Pharmaceuticals (CRNX) Q4 2024 Earnings

12NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.96

-0.91

-0.86

-0.81

Details

Expected EPS

-0.910672

Actual EPS

-0.96

Surprise EPS

-0.05

Surprise Percent

+5.42%

Description

Crinetics Pharmaceuticals (CRNX) has reported earnings of -0.96 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.